Opioids and Sleep Medication Use After Surgery for Early Stage Lung Cancer: A SEER-Medicare Analysis

被引:0
|
作者
Tuminello, S. [1 ,2 ]
Wisnivesky, J. [3 ,4 ]
Schwartz, R. [5 ,6 ]
Liu, B. [2 ,7 ]
Mhango, G. [3 ,4 ]
Flores, R. R. [8 ]
Taioli, E. [9 ]
机构
[1] Icahn Sch Med Mt Sinai, Populat Hlth Sci & Policy, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Zucker Sch Med Hofstra Northwell, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Zucker Sch Med Hofstra Northwell, Inst Translat Epidemiol, New York, NY 10029 USA
[7] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[8] Icahn Sch Med Mt Sinai, Dept Thorac Surg, New York, NY 10029 USA
[9] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Populat Hlth Sci & Policy, New York, NY 10029 USA
关键词
VATS; NSCLC; Opioids;
D O I
10.1016/j.jtho.2018.08.316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA01.05
引用
收藏
页码:S355 / S355
页数:1
相关论文
共 50 条
  • [1] Use of SEER-Medicare data for measuring cancer surgery
    Cooper, GS
    Virnig, B
    Klabunde, CN
    Schlussler, N
    Freeman, J
    Warren, JL
    MEDICAL CARE, 2002, 40 (08) : 43 - 48
  • [2] Effect of Chemoradiotherapy before and after Surgery for Esophageal Cancer: A SEER-Medicare Analysis
    Hong, J. C.
    Koong, A. C.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S314 - S314
  • [3] FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Neugut, Alfred I.
    Lin, Aijing
    Raab, Gabriel T.
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Kiran, Ravi P.
    Wright, Jason
    Hershman, Dawn L.
    CLINICAL COLORECTAL CANCER, 2019, 18 (02) : 133 - 140
  • [4] Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis
    Hong, Julian C.
    Murphy, James D.
    Wang, Samuel J.
    Koong, Albert C.
    Chang, Daniel T.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3999 - 4007
  • [5] Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare Analysis
    Julian C. Hong
    James D. Murphy
    Samuel J. Wang
    Albert C. Koong
    Daniel T. Chang
    Annals of Surgical Oncology, 2013, 20 : 3999 - 4007
  • [6] Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Raab, Gabriel T.
    Lin, Aijing
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Buono, Donna L.
    Hur, Chin
    Kiran, Ravi P.
    Wright, Jason D.
    Hershman, Dawn L.
    Neugut, Alfred I.
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E294 - E299
  • [7] Trends in Use of Postprostatectomy Therapies for Prostate Cancer: A SEER-Medicare Analysis
    Sheets, N. C.
    Hendrix, L. H.
    Allen, I. M.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S544 - S544
  • [8] The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis
    Jeon, Christie Y.
    Pandol, Stephen J.
    Wu, Bechien
    Cook-Wiens, Galen
    Gottlieb, Roberta A.
    Merz, Noel Bairey
    Goodman, Marc T.
    PLOS ONE, 2015, 10 (04):
  • [9] Trends in the utilization of adjuvant chemotherapy in early stage endometrial cancer: a SEER-Medicare study
    Garg, G.
    Schwartz, K.
    Kumar, S.
    Morris, R. T.
    Ali-Fehmi, R.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (04) : 547 - 554
  • [10] Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data
    West, Howard
    Hu, Xiaohan
    Zhang, Su
    Song, Yan
    Chirovsky, Diana
    Gao, Chi
    Lerner, Ariel
    Jiang, Anya
    Signorovitch, James
    Samkari, Ayman
    CLINICAL LUNG CANCER, 2023, 24 (03) : 260 - 268